VIX Streak in Jeopardy as Healthcare Vote Sparks Volatility

The stock market stumbled this week, as uncertainty swirled around House Republicans efforts to dismantle the Affordable Care Act (ACA)

Mar 24, 2017 at 1:25 PM
facebook twitter linkedin


All eyes were on Washington, D.C., this week, as President Donald Trump and House Republicans scrambled to find the votes to pass a healthcare bill repealing Obamacare. The vote, initially slated for Thursday, was delayed until today, with Trump giving Republican holdouts an ultimatum to pass the American Health Care Act (AHCA), or the Affordable Care Act (ACA) will remain in place. Stocks didn't react well to the uncertainty, with the Dow poised for its worst week since the election, and the S&P 500 Index (SPX) and Nasdaq Composite (COMP) set to end the week with losses of more than 1%, even as the COMP explored record highs early on.

VIX Comes Off Historically Low Levels

Against this backdrop, and one day after a mountain of VIX call options expired, the CBOE Volatility Index (VIX) on March 23 marked its highest close since 2016 -- and could be on track to snap this relatively rare VIX streak of weeks without a move of 10% or more. Nevertheless, VIX continues to hover at historically low levels, which could bode well for stocks over the longer term.

Healthcare Shares in Focus as House Vote Looms

Not surprisingly, the healthcare sector was in focus, with options traders quick to place short-term bets on the Health Care Select Sector SPDR Fund (XLV), the iShares Nasdaq Biotechnology ETF (IBB), and the SPDR S&P Biotech ETF (XBI). Elsewhere, a number of biotechs made big moves following successful drug trials. Shares of chronic pain specialist Nektar Therapeutics (NASDAQ:NKTR) shot to a 10-year high, while Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) plunged after its treatment for seizures failed in a mid-stage study. Fellow drug stock Flexion Therapeutics Inc (NASDAQ:FLXN) jumped more than 33% on reports of a potential $1 billion bid from Sanofi SA (ADR) (NYSE:SNY).

Apple, Disney Stocks Trade at New Highs

There was plenty of action to be had outside of the healthcare sector, though. Among Dow stocks, Walt Disney Co (NYSE:DIS) started the week hitting an all-time peak, following a blowout box office for "Beauty and the Beast" -- and DIS stock could be ready to continue its hot streak. Apple Inc. (NASDAQ:AAPL) continued to bask in analysts' bullish limelight -- sending the shares even further into uncharted territory -- with Barron's telling traders that it wasn't time to sell Apple stock. Likewise, analysts took a glass-half-full approach to Nike stock ahead of earnings -- unlike NKE options traders -- and though the shares took a post-earnings tumble, they managed to bounce off their rising 200-day moving average.

Falling Oil Prices Spark Bearish Options Trading

Meanwhile, falling oil prices put the pressure on energy shares -- drawing a rare batch of put buyers to the SPDR S&P Oil & Gas Exploration & Production ETF (XOP). Additionally, one United States Oil Fund (USO) options trader appeared to place a $4 million bet on a lower oil prices. While crude oil is on track for a weekly loss, the U.S. dollar is also poised to close lower on the week. Nevertheless, the put writer who set a short-term floor for the PowerShares DB US Dollar Bullish ETF (UUP) is poised to pocket the full potential reward on the trade, after identifying the significance of UUP $25.50.

Snap Stock Gets "Buy" Ratings 

FANG stocks also saw their fair share of headlines, with options traders buying puts on Alphabet Inc (NASDAQ:GOOGL) amid Google ads backlash. Netflix, Inc. (NASDAQ:NFLX), meanwhile, briefly pulled back after notching its highest mark to date, but found a foothold atop its historically bullish 40-day trendline -- a potential "buy" signal also flashing on Amazon.com, Inc. (NASDAQ:AMZN). Elsewhere on the tech circuit, Snapchat parent Snap Inc (NYSE:SNAP) earned its first "buy" ratings from analysts -- sending SNAP stock nearly 17% higher week-to-date. Chipmaker Micron Technology, Inc. (NASDAQ:MU) also appears set to close out the week with impressive gains, with MU stock trading in two-year-high territory, following the company's impressive earnings report.

Fed Speeches Headline Next Week's Stock Market Action

Looking ahead, next week's action will be dominated by Fed speeches -- and interest-rate chatter could continue to keep bank shares and gold stocks front and center. With stocks struggling this week, we'll continue to keep our eye on sentiment polls, too, as signs suggest doubt is slowly creeping back into the stock market. And while bulls should be hoping for an SEC Sweet 16 win over the weekend, it's always a good reminder to take random stock market indicators with a grain of salt.

Make the Most of the next Expiration Week Countdown!


 




 
Special Offers from Schaeffer's Trading Partners